RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency

被引：49

作者：

Collis, AJ ^{[1
]}

Foster, ML ^{[1
]}

Halley, F ^{[1
]}

Maslen, C ^{[1
]}

McLay, IM ^{[1
]}

Page, KM ^{[1
]}

Redford, EJ ^{[1
]}

Souness, JE ^{[1
]}

Wilsher, NE ^{[1
]}

机构：

[1] Dagenham Res Ctr, Aventis Pharma, Dagenham RM10 7XS, Essex, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 05期

关键词：

D O I：

10.1016/S0960-894X(01)00034-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Following the discovery of RPR200765, a series of pyrimidine analogues have been prepared as backups. Amongst them, RPR203494 was identified with a better in vitro profile than RPR200765A. (C) 2001 Elsevier Science Ltd. All rights reserved.

引用

页码：693 / 696

页数：4

共 10 条

[1] Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes
Adams, JL
Boehm, JC
Kassis, S
Gorycki, PD
Webb, EF
Hall, R
Sorenson, M
Lee, JC
Ayrton, A
Griswold, DE
Gallagher, TF
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (22) : 3111 - 3116
[2] Badger AM, 2000, ARTHRITIS RHEUM, V43, P175, DOI 10.1002/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO
[3] 2-S
[4] Computational methods for the prediction of 'drug-likeness'
Clark, DE
Pickett, SD
[J]. DRUG DISCOVERY TODAY, 2000, 5 (02) : 49 - 58
[5] COOK DC, UNPUB ORG PROCESS RE
[6] LEE JC, 1994, NATURE, V372, P736
[7] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Lipinski, CA
Lombardo, F
Dominy, BW
Feeney, PJ
[J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) : 3 - 25
[8] Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase
Liverton, NJ
Butcher, JW
Claiborne, CF
Claremon, DA
Libby, BE
Nguyen, KT
Pitzenberger, SM
Selnick, HG
Smith, GR
Tebben, A
Vacca, JP
Varga, SL
Agarwal, L
Dancheck, K
Forsyth, AJ
Fletcher, DS
Frantz, B
Hanlon, WA
Harper, CF
Hofsess, SJ
Kostura, M
Lin, J
Luell, S
O'Neill, EA
Orevillo, CJ
Pang, M
Parsons, J
Rolando, A
Sahly, Y
Visco, DM
O'Keefe, SJ
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) : 2180 - 2190
[9] The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy
McLay, IM
Halley, F
Souness, JE
McKenna, J
Benning, V
Birrell, M
Burton, B
Belvisi, M
Collis, A
Constan, A
Foster, M
Hele, D
Jayyosi, Z
Kelley, M
Maslen, C
Miller, G
Ouldelhkim, MC
Page, K
Phipps, S
Pollock, K
Porter, B
Ratcliffe, AI
Redford, EJ
Webber, S
Slater, B
Thybaud, V
Wilsher, N
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (02) : 537 - 554
[10] Muller-Ladner U, 1996, Curr Opin Rheumatol, V8, P210

← 1 →